QT IMAGING HOLDINGS, INC. Current Liabilities
QT IMAGING HOLDINGS, INC. (QTI) had Current Liabilities of $9.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $9.50M.
- 2026-03-31: Liabilities, Current $8.53M.
- 2025-12-31: Liabilities, Current $7.87M.
- 2025-09-30: Liabilities, Current $12.74M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.50M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.53M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.87M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $12.74M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.31M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.28M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $9.79M 10-K · filed 2026-03-25 | $9.79M 10-K · filed 2025-03-31 |
| 2024-09-30 | $5.43M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $15.27M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.37M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $7.34M 10-K · filed 2025-03-31 | $12.68M 10-K · filed 2024-03-25 |
| 2023-09-30 | $8.93M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.02M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.40M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.19M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $2.65M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.57M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $832.33K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $633.64K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.53M 10-Q/A · filed 2022-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |